Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Clinical trial NCT05997615 · RECRUITING

Trial details

NCT number: NCT05997615
Sponsor: Vir Biotechnology, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hormone-refractory Prostate Cancer

Start date: 2023-08-10
Primary completion: 2027-09-29
Enrollment: 437

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.